Risk Factors for 1-Year Mortality, According to Multivariable Cox Proportional Hazard Regression Analyses
| . | Deaths (%) . | HR (95% CI) . | P value . | aHR (95% CI) . | P value . |
|---|---|---|---|---|---|
| HBsAg (%) | |||||
| Negative | 102/1673 (6.1) | Ref. | Ref. | ||
| Positive | 27/276 (9.8) | 1.61 (1.05–2.45) | .03 | 1.21 (0.74–1.98) | .45 |
| WHO stage (%) | |||||
| 1 or 2 | 50/1203 (4.2) | Ref. | Ref. | ||
| 3 or 4 | 79/732 (10.8) | 2.69 (1.88–3.83) | <.001 | 1.42 (0.93–2.17) | .10 |
| CD4 cell count (%) | |||||
| ≥200 cells/µL | 41/973 (4.2) | Ref. | Ref. | ||
| <200 cells/µL | 71/640 (11.1) | 2.76 (1.88–4.05) | <.001 | 2.02 (1.33–3.07) | .001 |
| BMI (%) | |||||
| ≥18.5 kg/m2 | 48/1275 (3.8) | Ref. | Ref. | ||
| <18.5 kg/m2 | 67/519 (12.9) | 3.60 (2.49–5.22) | <.001 | 2.66 (1.76–4.02) | <.001 |
| Sex (%) | |||||
| Female | 52/1240 (4.2) | Ref. | Ref. | ||
| Male | 77/708 (10.9) | 2.63 (1.85–3.74) | <.001 | 1.72 (1.13–2.62) | .01 |
| Age (%) | |||||
| <30 years | 43/772 (5.6) | Ref. | Ref. | ||
| ≥30 years | 86/1176 (7.3) | 1.29 (0.89–1.85) | .18 | 0.97 (0.63–1.50) | .89 |
| . | Deaths (%) . | HR (95% CI) . | P value . | aHR (95% CI) . | P value . |
|---|---|---|---|---|---|
| HBsAg (%) | |||||
| Negative | 102/1673 (6.1) | Ref. | Ref. | ||
| Positive | 27/276 (9.8) | 1.61 (1.05–2.45) | .03 | 1.21 (0.74–1.98) | .45 |
| WHO stage (%) | |||||
| 1 or 2 | 50/1203 (4.2) | Ref. | Ref. | ||
| 3 or 4 | 79/732 (10.8) | 2.69 (1.88–3.83) | <.001 | 1.42 (0.93–2.17) | .10 |
| CD4 cell count (%) | |||||
| ≥200 cells/µL | 41/973 (4.2) | Ref. | Ref. | ||
| <200 cells/µL | 71/640 (11.1) | 2.76 (1.88–4.05) | <.001 | 2.02 (1.33–3.07) | .001 |
| BMI (%) | |||||
| ≥18.5 kg/m2 | 48/1275 (3.8) | Ref. | Ref. | ||
| <18.5 kg/m2 | 67/519 (12.9) | 3.60 (2.49–5.22) | <.001 | 2.66 (1.76–4.02) | <.001 |
| Sex (%) | |||||
| Female | 52/1240 (4.2) | Ref. | Ref. | ||
| Male | 77/708 (10.9) | 2.63 (1.85–3.74) | <.001 | 1.72 (1.13–2.62) | .01 |
| Age (%) | |||||
| <30 years | 43/772 (5.6) | Ref. | Ref. | ||
| ≥30 years | 86/1176 (7.3) | 1.29 (0.89–1.85) | .18 | 0.97 (0.63–1.50) | .89 |
Abbreviations: aHR, adjusted hazard ratio; BMI, body mass index; CI, confidence interval; HBsAg, hepatitis B surface antigen; HR, hazard ratio; WHO, World Health Organization.
Risk Factors for 1-Year Mortality, According to Multivariable Cox Proportional Hazard Regression Analyses
| . | Deaths (%) . | HR (95% CI) . | P value . | aHR (95% CI) . | P value . |
|---|---|---|---|---|---|
| HBsAg (%) | |||||
| Negative | 102/1673 (6.1) | Ref. | Ref. | ||
| Positive | 27/276 (9.8) | 1.61 (1.05–2.45) | .03 | 1.21 (0.74–1.98) | .45 |
| WHO stage (%) | |||||
| 1 or 2 | 50/1203 (4.2) | Ref. | Ref. | ||
| 3 or 4 | 79/732 (10.8) | 2.69 (1.88–3.83) | <.001 | 1.42 (0.93–2.17) | .10 |
| CD4 cell count (%) | |||||
| ≥200 cells/µL | 41/973 (4.2) | Ref. | Ref. | ||
| <200 cells/µL | 71/640 (11.1) | 2.76 (1.88–4.05) | <.001 | 2.02 (1.33–3.07) | .001 |
| BMI (%) | |||||
| ≥18.5 kg/m2 | 48/1275 (3.8) | Ref. | Ref. | ||
| <18.5 kg/m2 | 67/519 (12.9) | 3.60 (2.49–5.22) | <.001 | 2.66 (1.76–4.02) | <.001 |
| Sex (%) | |||||
| Female | 52/1240 (4.2) | Ref. | Ref. | ||
| Male | 77/708 (10.9) | 2.63 (1.85–3.74) | <.001 | 1.72 (1.13–2.62) | .01 |
| Age (%) | |||||
| <30 years | 43/772 (5.6) | Ref. | Ref. | ||
| ≥30 years | 86/1176 (7.3) | 1.29 (0.89–1.85) | .18 | 0.97 (0.63–1.50) | .89 |
| . | Deaths (%) . | HR (95% CI) . | P value . | aHR (95% CI) . | P value . |
|---|---|---|---|---|---|
| HBsAg (%) | |||||
| Negative | 102/1673 (6.1) | Ref. | Ref. | ||
| Positive | 27/276 (9.8) | 1.61 (1.05–2.45) | .03 | 1.21 (0.74–1.98) | .45 |
| WHO stage (%) | |||||
| 1 or 2 | 50/1203 (4.2) | Ref. | Ref. | ||
| 3 or 4 | 79/732 (10.8) | 2.69 (1.88–3.83) | <.001 | 1.42 (0.93–2.17) | .10 |
| CD4 cell count (%) | |||||
| ≥200 cells/µL | 41/973 (4.2) | Ref. | Ref. | ||
| <200 cells/µL | 71/640 (11.1) | 2.76 (1.88–4.05) | <.001 | 2.02 (1.33–3.07) | .001 |
| BMI (%) | |||||
| ≥18.5 kg/m2 | 48/1275 (3.8) | Ref. | Ref. | ||
| <18.5 kg/m2 | 67/519 (12.9) | 3.60 (2.49–5.22) | <.001 | 2.66 (1.76–4.02) | <.001 |
| Sex (%) | |||||
| Female | 52/1240 (4.2) | Ref. | Ref. | ||
| Male | 77/708 (10.9) | 2.63 (1.85–3.74) | <.001 | 1.72 (1.13–2.62) | .01 |
| Age (%) | |||||
| <30 years | 43/772 (5.6) | Ref. | Ref. | ||
| ≥30 years | 86/1176 (7.3) | 1.29 (0.89–1.85) | .18 | 0.97 (0.63–1.50) | .89 |
Abbreviations: aHR, adjusted hazard ratio; BMI, body mass index; CI, confidence interval; HBsAg, hepatitis B surface antigen; HR, hazard ratio; WHO, World Health Organization.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
